Posted April 7, 2009
Researcher Dr. Rob Moir, a member of the Cure Alzheimer’s Fund Oligomer Collaborative, and researcher at Massachusetts General Hospital in Boston, presented research supported by Cure Alzheimer’s Fund in March to the International Conference on Alzheimer’s Disease/Parkinson’s Disease that points to evidence that the Abeta peptide, acknowledged to be implicated in the cause of AD, may in fact be a “part of our evolutionary ancient innate immune system.” The work is a collaboration between Dr. Moir, Dr. Rudy Tanzi, Chair of the Cure Alzheimer’s Fund Research Consortium, and infectious disease expert, Dr. James Kirby (Harvard Medical School).
Read the entire article by AlzForum’s Gabrielle Strobel >
